2019
Improved Diagnostic Yield and Specimen Quality With Endobronchial Ultrasound-Guided Forceps Biopsies: A Retrospective Analysis
Ray AS, Li C, Murphy TE, Cai G, Araujo KLB, Bramley K, DeBiasi EM, Pisani MA, Cortopassi IO, Puchalski JT. Improved Diagnostic Yield and Specimen Quality With Endobronchial Ultrasound-Guided Forceps Biopsies: A Retrospective Analysis. The Annals Of Thoracic Surgery 2019, 109: 894-901. PMID: 31593653, PMCID: PMC9376016, DOI: 10.1016/j.athoracsur.2019.08.106.Peer-Reviewed Original ResearchConceptsStandard of careTransbronchial needle aspirationDiagnostic yieldHilar lymphadenopathyEndobronchial ultrasound transbronchial needle aspirationMediastinal/hilar lymphadenopathySolid organ malignanciesHigh diagnostic yieldGood tissue qualitySpecimen qualityForceps biopsyEBUS-TBNAParenchymal findingsPreprocedural imagingEndobronchial ultrasoundNeedle aspirationRetrospective analysisLymphadenopathyDiagnostic criteriaPatient basisDisease processTissue acquisitionPatientsClinical scenariosSarcoidosis
2017
Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT
Gao SJ, Kim AW, Puchalski JT, Bramley K, Detterbeck FC, Boffa DJ, Decker RH. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT. Lung Cancer 2017, 109: 36-41. PMID: 28577947, DOI: 10.1016/j.lungcan.2017.04.018.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungClinical Decision-MakingDiagnostic ImagingFemaleHumansLung NeoplasmsMaleMediastinumMiddle AgedNeoplasm MetastasisNeoplasm StagingPatient SelectionPositron Emission Tomography Computed TomographyPractice Guidelines as TopicRetrospective StudiesConceptsOccult N2 diseaseOccult N2 metastasesGround-glass componentInvasive mediastinal stagingCurative-intent therapyT2 tumorsN2 metastasisPET-CTInvasive stagingN2 diseaseT1 tumorsNegative predictive valueMediastinal stagingEarly non-small cell lung cancerExact testPredictive valueSolid tumorsNon-small cell lung cancerClinical stage I NSCLCN2 lymph nodesNode-negative NSCLCOccult nodal involvementPure-solid tumorsStage I NSCLCT1-2N0 disease